Analysis showed that high expression levels of SMAD1, SMAD2, and SMAD4 are associated with a better survival rate of gastric cancer patients, whereas SMAD3, SMAD5, SMAD6, SMAD7 and SMAD9 are associated with poor prognosis. Here, SMAD5 is linked to gastric cancer.